U.S. markets closed

  • S&P 500

    4,119.21
    +42.61 (+1.05%)
     

  • Dow 30

    34,092.96
    +6.92 (+0.02%)
     

  • Nasdaq

    11,816.32
    +231.77 (+2.00%)
     

  • Russell 2000

    1,960.81
    +28.87 (+1.49%)
     

  • Crude Oil

    76.80
    +0.39 (+0.51%)
     

  • Gold

    1,968.20
    +25.40 (+1.31%)
     

  • Silver

    24.12
    +0.51 (+2.16%)
     

  • EUR/USD

    1.1023
    +0.0157 (+1.44%)
     

  • 10-Yr Bond

    3.3970
    -0.1320 (-3.74%)
     

  • GBP/USD

    1.2400
    +0.0084 (+0.68%)
     

  • USD/JPY

    128.5830
    -1.4850 (-1.14%)
     

  • BTC-USD

    23,722.58
    +600.18 (+2.60%)
     

  • CMC Crypto 200

    538.70
    +296.03 (+121.98%)
     

  • FTSE 100

    7,761.11
    -10.59 (-0.14%)
     

  • Nikkei 225

    27,346.88
    +19.77 (+0.07%)
     

Analyst Sees Market Potential For Arcellx Multiple Myeloma Candidate, Sees 50% Upside In Stock

Vandana Singh
·1 min read

  • Needham initiated coverage on Arcellx Inc (NASDAQ: ACLX) with a Buy rating and a price target of $31.

  • Arcellx's lead program and main value driver is CART-ddBCMA, an autologous CAR-T therapy for relapsed or refractory (r/r) multiple myeloma (MM).

  • With two CAR-Ts already on the market - Bristol Myers Squibb Co's (NYSE: BMY) Abecma and Johnson & Johnson's (NYSE: JNJ) Carvykti, Arcellx is a fast follower.

  • The analyst says that early data for CART-ddBCMA supports an efficacy profile in line with the market leader (Carvykti).

  • While the MM market is crowded, Needham analyst believes CAR-Ts have demonstrated the best activity and that the incumbents are insufficient, given market needs.

  • A physician survey identified access as a key issue, finding that only 35% of CAR-T-eligible patients receive treatment.

  • Assuming 20% market penetration, CART-ddBCMA sales are estimated to reach $3 billion in 2033.

  • Broader platform play (ARC-SparX) could also add a potential upside. A clinical update is expected in 4Q:22, with a pivotal study in 2023.

  • Price Action: ACLX shares are up 1.70% at $20.62 on the last check Thursday.

Latest Ratings for ACLX

Date

Firm

Action

From

To

Mar 2022

SVB Leerink

Initiates Coverage On

Outperform

Mar 2022

B of A Securities

Initiates Coverage On

Buy

View More Analyst Ratings for ACLX

View the Latest Analyst Ratings

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories

  • Meta stock soars after hours, analyst warns of 'magnitude' of move

    Brent Thill, Jefferies Equity Research Analyst, analyzes Meta's stock pop after earnings. You can see the full interview here. Key video highlights 00:25 On how Instagram has improved 00:40 On better ad targeting 00:55 On other social platforms 01:30 On the stock move

  • Meta beats Q4 estimates on both the top and bottom lines

    Tech editor Dan Howley takes a closer look at Meta's latest earnings beat alongside updates to its share buyback program.

  • Tech earnings preview: What to expect when Alphabet, Amazon, Apple report on Thursday

    Thursday is a big day for tech earnings as Alphabet, Amazon and Apple all are set to report their quarterly results. 

  • Ask an Advisor: I Am 60 Years Old, Have $1.1M Cash, $880K in a 401(k), Several Pensions and Social Security. Should I Retire Now?

    I am 60 years old, married, with no mortgage. We also have $1.1 million in liquid cash and $880,000 in a 401(k). I will have two pensions, which have not started yet, and my wife will have one pension, all … Continue reading → The post Ask an Advisor: I Am 60 Years Old, Have $1.1M Cash, $880K in a 401(k), Several Pensions and Social Security. Should I Retire Now? appeared first on SmartAsset Blog.

  • Cathie Wood pours millions into these 2 stocks — this is what makes them attractive buys

    January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11% into the green, in what amounted to its best start to a year since 2001. That signals the appetite for risk is on again and that will be good news for Cathie Wood, the ARK Investment CEO, whose investing style heavily favors disruptors - equities that are naturally positioned at the risky end of the sca

  • Tesla's Musk Creates New Expectations Around the Cybertruck

    Tesla's Cybertruck is the object of endless speculation. Sci-fi vehicle, some enthused fans of Tesla and CEO Elon Musk say. Since its introduction in November 2019 at a promotional event in Los Angeles, the Cybertruck has captured the hearts of Tesla fans.

  • Here's the Most Important Number in SoFi's Earnings

    SoFi (NASDAQ: SOFI) recently reported fourth-quarter earnings that were extremely impressive. But there's one number that I'm most excited about, and it isn't any of the headline stats. In this short video, I run down the highlights of the quarter and the most important number for investors to watch.

  • Citing 'operational efficiencies,' DraftKings cuts 140 jobs

    DraftKings Inc. has joined Wayfair Inc., HubSpot Inc. and other publicly traded tech companies in Massachusetts in laying off workers.

  • Wall Street Bulls Look Optimistic About NIO Inc. (NIO): Should You Buy?

    According to the average brokerage recommendation (ABR), one should invest in NIO Inc. (NIO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

  • Billionaire Charlie Munger Reveals The Reason Berkshire Hathaway Is Sitting On $88 Billion in Cash

    The S&P 500 dipped by 19% in 2022, but stocks still don’t seem cheap to Charlie Munger, Warren Buffett’s billionaire partner at Berkshire Hathaway. “In my whole adult life, I have never hoarded cash, waiting for better conditions,” Munger said in an interview in late 2022. “I’ve just invested in the best thing I could find.” Yet he acknowledged that Berkshire Hathaway is sitting on billions of dollars in cash. The reason isn’t that Buffett and Munger think they can wait for stocks to get even ch

  • Fed Chair Powell remains noncommittal on future interest rate hike plans

    Yahoo Finance Live's Seana Smith and Dave Briggs monitor market movements following Fed Chair Jerome Powell's press conference addressing the future interest rate hikes to come in 2023.

  • As Fed raises rates by a quarter point, here’s where financial advisers are telling their clients to invest — and store — their money

    The Federal Reserve boosted its influential interest rate yet again Wednesday, even as more signs indicate that inflation is cooling. It hiked the benchmark’s key rate by a quarter of a basis point, bringing it to the 4.5%–4.75% range. One basis point is equal to one hundredth of a percentage point.

  • Meta earnings: Zuckerberg is ‘clearly listening to Wall Street,’ analyst says

    Jefferies Senior Analyst Brent Thill assesses Meta's Q4 earnings beat, the social media company's outlook amid tech industry layoffs, and user engagement on the platform.

  • 3 Big Reasons to Sell Cassava Sciences Stock Right Now

    On any list of biotech plays that might multiply in value in a relatively short period, Cassava Sciences (NASDAQ: SAVA) is likely to be near the top of the list. It's exploring whether its drug called simufilam is safe and effective to treat early-stage Alzheimer's disease, though its clinical trials have (so far) shed little light on the issue. The biggest reason to sell Cassava stock: After an open-label phase 2 clinical trial of simufilam, the market reacted quite negatively to the release of new data that management spun as being positive.

  • AMD tops Q4 earnings expectations despite slowing PC sales

    Yahoo Finance’s Daniel Howley joins the Live show to discuss quarterly earnings for AMD, the drop in PC sales and shipments, and the outlook for AMD.

  • 3 Juicy Dividend Stocks in Warren Buffett's Secret Portfolio to Buy in February

    Want to know which stocks Warren Buffett owns? Many investors don't realize that there's another group of stocks Buffett owns in addition to the stocks listed in Berkshire's 13-F documents. New England Asset Management (NEAM) is an investment firm that's a wholly owned subsidiary of Berkshire Hathaway.

  • How Long Will $1,500,000 Last Me in Retirement?

    If you find yourself with $1.5 million in retirement savings, you're doing more than five times better than the average retiree, who only has $279,997. It is true that $1.5 million can last indefinitely in retirement if you don't spend … Continue reading → The post How Long Will $1,500,000 Last in Retirement? appeared first on SmartAsset Blog.

  • Biden Promises to Veto Bill to Abolish the IRS and Introduce One National Tax Rate if It Passes

    Right now, the average price for a loaf of bread is, approximately, $1.87. Under a new law proposed by House Republicans, that price would go up to more than $2.50. This would be the result of the Fair Tax Act, … Continue reading → The post Congress to Vote on Whether to Abolish the IRS and Introduce One National Tax Rate appeared first on SmartAsset Blog.

  • Which Billionaire Owns The Most Land In The U.S.? Hint, It's Not Bill Gates

    Earlier this year, in May, claims were made that Microsoft Corp co-founder Bill Gates owned the majority of America’s farmland. While that is false, with the billionaire amassing nearly 270,000 acres of farmland across the country, compared to 900 million total farm acres, a different billionaire privately owns 2.2 million acres, making him the largest landowner in the U.S. John Malone, the former CEO of Tele-Communications Inc., which AT&T Inc. purchased for more than $50 billion in 1999, has a

  • Apple earnings will be the latest sign the tech industry is coming back to Earth

    If Apple's earnings hue closely to analysts' predictions, it'll be just the latest sign that the tech industry is on the downswing.